Open access peer-reviewed chapter

Inhibition of Tumor Growth and Metastasis by a Combination of Anti-VEGF-C and Enhanced IL-12 Therapy in an Immunocompetent Mouse Mammary Cancer Model

By Masa-Aki Shibata, Junji Morimoto, Eiko Shibata, Mariko Harada-Shiba and Shigekazu Fujioka

Submitted: March 24th 2011Reviewed: July 12th 2011Published: November 9th 2011

DOI: 10.5772/30904

Downloaded: 1147

© 2011 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Masa-Aki Shibata, Junji Morimoto, Eiko Shibata, Mariko Harada-Shiba and Shigekazu Fujioka (November 9th 2011). Inhibition of Tumor Growth and Metastasis by a Combination of Anti-VEGF-C and Enhanced IL-12 Therapy in an Immunocompetent Mouse Mammary Cancer Model, Breast Cancer Esra Gunduz, IntechOpen, DOI: 10.5772/30904. Available from:

Embed this chapter on your site Copy to clipboard

<iframe src="http://www.intechopen.com/embed/breast-cancer-current-and-alternative-therapeutic-modalities/inhibition-of-tumor-growth-and-metastasis-by-a-combination-of-anti-vegf-c-and-enhanced-il-12-therapy" />

Embed this code snippet in the HTML of your website to show this chapter

chapter statistics

1147total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Roles and Mechanisms of Estrogen and Estrogen Receptors in Breast Cancer Resistant to Chemotherapy

By Weimin Fan and Meihua Sui

Related Book

First chapter

EGFR-Ligand Signaling in Breast Cancer Metastasis: Recurring Developmental Themes

By Nicole K. Nickerson, Jennifer L. Gilmore, Kah Tan Allen, David J. Riese II, Kenneth P. Nephew and John Foley

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

+3,550 Open Access Books

+57,400 Citations in Web of Science

+108,500 IntechOpen Authors and Academic Editors

+560,000 Unique visitors per month

More about us